NTP
This article was originally published in The Rose Sheet
Executive Summary
Di(2-ethylhexyl) phthalate monograph will be released in October by National Toxicology Program's Center for the Evaluation of Risks to Human Reproduction, agency reports during Board of Scientific Counselors Meeting Sept. 10-11 in Research Triangle Park, N.C. NTP released a monograph on di-n-butyl phthalate in March (1"The Rose Sheet" March 24, 2003, p. 6). Agency also unveiled its draft vision for the toxicology program, which advocates shifting basis for decision-making to rely on faster, mechanism-based assays rather than empirical tests. NTP anticipates developing more specific draft principles, roadmap of goals to be accomplished under new strategy by July 2004...
You may also be interested in...
Di-N-Butyl Phthalate Monograph Released By NTP
The National Toxicology Program has "some concern" di-n-butyl phthalate causes adverse effects to human development, particularly development of the reproductive system, according to a monograph released by NTP's Center for the Evaluation of Risks to Human Reproduction in a 1March 18 Federal Register notice
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.